Xuan Marian Thai

Array ( [id] => 5574991 [patent_doc_number] => 20090142352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 12/197093 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 153 [patent_figures_cnt] => 153 [patent_no_of_words] => 72994 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142352.pdf [firstpage_image] =>[orig_patent_app_number] => 12197093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575445 [patent_doc_number] => 20090142807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'FUSION PARTNER FOR PRODUCTION OF MONOCLONAL RABBIT ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/196234 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7219 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142807.pdf [firstpage_image] =>[orig_patent_app_number] => 12196234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4464985 [patent_doc_number] => 07935792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Antibody reacting with N-acetylglucosamine-6-O-sulfotransferase product' [patent_app_type] => utility [patent_app_number] => 12/194441 [patent_app_country] => US [patent_app_date] => 2008-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13787 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935792.pdf [firstpage_image] =>[orig_patent_app_number] => 12194441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564149 [patent_doc_number] => 20090137002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'ANTI EPHB4 ANTIBODIES AND ANTIBODY FRAGMENTS' [patent_app_type] => utility [patent_app_number] => 12/182235 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 18011 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137002.pdf [firstpage_image] =>[orig_patent_app_number] => 12182235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509066 [patent_doc_number] => 20090082273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/218759 [patent_app_country] => US [patent_app_date] => 2008-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 22154 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082273.pdf [firstpage_image] =>[orig_patent_app_number] => 12218759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026731 [patent_doc_number] => 08536313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Monoclonal antibody having neutralizing activity against MMP13' [patent_app_type] => utility [patent_app_number] => 12/668201 [patent_app_country] => US [patent_app_date] => 2008-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 7020 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12668201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245573 [patent_doc_number] => 20100135986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'COMPOSITIONS FOR ANTI-FIBRINOLYTIC TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/452280 [patent_app_country] => US [patent_app_date] => 2008-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6525 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20100135986.pdf [firstpage_image] =>[orig_patent_app_number] => 12452280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291164 [patent_doc_number] => 20090023894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Neutralizing Antibody Against HGF' [patent_app_type] => utility [patent_app_number] => 12/145643 [patent_app_country] => US [patent_app_date] => 2008-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7909 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023894.pdf [firstpage_image] =>[orig_patent_app_number] => 12145643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760194 [patent_doc_number] => 20080312420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Monoclonal Antibodies for Detection of Urinary Trypsin Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/144909 [patent_app_country] => US [patent_app_date] => 2008-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10246 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312420.pdf [firstpage_image] =>[orig_patent_app_number] => 12144909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9454950 [patent_doc_number] => 08715954 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Method of producing C3A serum-free clonal cell line' [patent_app_type] => utility [patent_app_number] => 12/143631 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 7 [patent_no_of_words] => 10783 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12143631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 173997 [patent_doc_number] => 07659376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Antibody that binds glyphosate resistance protein' [patent_app_type] => utility [patent_app_number] => 12/139408 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12708 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659376.pdf [firstpage_image] =>[orig_patent_app_number] => 12139408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823147 [patent_doc_number] => 20080227751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'METHOD AND AGENT FOR THE PREVENTION, INHIBITION AND TREATMENT OF SEPSIS' [patent_app_type] => utility [patent_app_number] => 12/128354 [patent_app_country] => US [patent_app_date] => 2008-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5929 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227751.pdf [firstpage_image] =>[orig_patent_app_number] => 12128354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099121 [patent_doc_number] => 08562993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Methods for treating GI syndrome and graft versus host disease' [patent_app_type] => utility [patent_app_number] => 12/599280 [patent_app_country] => US [patent_app_date] => 2008-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 48 [patent_no_of_words] => 26678 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12599280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343476 [patent_doc_number] => 20090182126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'GUANYLATE-BINDING PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/115428 [patent_app_country] => US [patent_app_date] => 2008-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 29494 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20090182126.pdf [firstpage_image] =>[orig_patent_app_number] => 12115428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340032 [patent_doc_number] => 20100247542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (MTOR) PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/598394 [patent_app_country] => US [patent_app_date] => 2008-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24296 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247542.pdf [firstpage_image] =>[orig_patent_app_number] => 12598394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415889 [patent_doc_number] => 20090041776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Production of cancer-specific antibodies in plants' [patent_app_type] => utility [patent_app_number] => 12/150078 [patent_app_country] => US [patent_app_date] => 2008-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13662 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041776.pdf [firstpage_image] =>[orig_patent_app_number] => 12150078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6550400 [patent_doc_number] => 20100233177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'MOLECULES AND METHODS FOR MODULATING PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 12/595538 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28820 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233177.pdf [firstpage_image] =>[orig_patent_app_number] => 12595538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563660 [patent_doc_number] => 20090136512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases' [patent_app_type] => utility [patent_app_number] => 12/059097 [patent_app_country] => US [patent_app_date] => 2008-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22512 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136512.pdf [firstpage_image] =>[orig_patent_app_number] => 12059097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452647 [patent_doc_number] => 20090068684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Serine and threoninephosphorylation sites' [patent_app_type] => utility [patent_app_number] => 12/079297 [patent_app_country] => US [patent_app_date] => 2008-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 33851 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068684.pdf [firstpage_image] =>[orig_patent_app_number] => 12079297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321921 [patent_doc_number] => 20100113575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHOD FOR DETECTING AUTOPROCESSED, SECRETED PCSK9' [patent_app_type] => utility [patent_app_number] => 12/593342 [patent_app_country] => US [patent_app_date] => 2008-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11815 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113575.pdf [firstpage_image] =>[orig_patent_app_number] => 12593342 [rel_patent_id] =>[rel_patent_doc_number] =>)